2019年内分泌学会针对有低血糖风险的老年2型糖尿病患者的质量测量指标集
内分泌学会于2019年3月成立技术专家小组,成员包括内分泌科医生、初级保健医生、糖尿病护理与教育专家/药师及一名患者,制定了3项门诊低血糖质量测量指标,旨在改善低血糖风险最高的2型糖尿病患者的诊疗质量。该指标集于2019年7月公开征求意见,基于公众反馈,最终指标集中删除了关于共享决策的第四项指标。
要点
- 内分泌学会2019年成立技术专家小组制定3项门诊低血糖质量测量指标。
- 指标针对65岁及以上、有低血糖风险的2型糖尿病患者。
- 基于2019年7月公众反馈,最终指标集删除了共享决策指标。
核心结论
- 缺乏针对老年2型糖尿病患者的门诊低血糖测量指标是改善诊疗和减少低血糖事件的障碍。
- 本文提供了3项测量指标的规格,可用于将质量改进工作聚焦于低血糖风险最高的患者。
研究设计与样本
- 内分泌学会于2019年3月成立技术专家小组,成员包括内分泌科医生、初级保健医生、糖尿病护理与教育专家/药师及一名患者。
- 该小组制定了3项门诊低血糖质量测量指标,指标集于2019年7月公开征求意见。
主要发现
- 技术专家小组制定了3项门诊低血糖质量测量指标。
- 基于公众反馈,最终指标集中删除了关于共享决策的第四项指标。
关键数值与推荐
- 3项门诊低血糖质量测量指标用于65岁及以上、有低血糖风险的2型糖尿病患者。
临床怎么用
- 原文指出该测量指标集可用于将质量改进工作聚焦于低血糖风险最高的2型糖尿病患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Hypoglycemia in the outpatient setting has a significant financial impact on the health care system and negative impact on a person's quality of life. Primary care physicians must address a multitude of issues in a visit with a person with type 2 diabetes mellitus (T2DM), often leaving little time to ask about hypoglycemia. OBJECTIVE: To develop quality measures that focus on outpatient hypoglycemia episodes for patients 65 and older with T2DM, which facilitate a clinician's ability to identify opportunities to improve the quality of care and reduce hypoglycemic episodes. PARTICIPANTS AND PROCESS: A technical expert panel established by the Endocrine Society in March 2019, which includes endocrinologists, primary care physicians, a diabetes care and education specialist/pharmacist, and a patient, developed 3 outpatient hypoglycemia quality measures. The measure set is intended to improve quality of care for patients with T2DM who are at greatest risk for hypoglycemia. The measures were available for public comment in July 2019. A fourth measure on shared decision-making was removed from the final measure set based on public feedback. CONCLUSION: A lack of outpatient hypoglycemia measures focusing on older adults with T2DM is a barrier to improving care of people with diabetes and reducing hypoglycemic episodes. This paper provides measure specifications for 3 measures that may be used to focus quality improvement efforts on patients at greatest risk for hypoglycemia.
引用
- Rosenzweig JL, Conlin PR, Gonzalvo JD, et al. 2019 Endocrine Society Measures Set for Older Adults With Type 2 Diabetes Who Are at Risk for Hypoglycemia. J Clin Endocrinol Metab. 2020. PMID: 31825487. doi:10.1210/clinem/dgz250
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。